U.S. markets open in 2 hours 49 minutes

Alkame Holdings, Inc. (ALKM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0032-0.0003 (-8.57%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0035
Open0.0033
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0028 - 0.0036
52 Week Range0.0002 - 0.0096
Volume67,121,195
Avg. Volume117,051,986
Market Cap17.6M
Beta (5Y Monthly)3.24
PE Ratio (TTM)N/A
EPS (TTM)-0.0030
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ACCESSWIRE

    Alkame Holdings Inc. Establishes New Asset Holdings Subsidiary for New Patents and IP

    LAS VEGAS, NV / ACCESSWIRE / February 24, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), a publicly traded health & wellness holding company, is pleased to announce that the company has completed the formation of Alkame Assets, LLC a new wholly owned subsidiary to house new patents and the company's associated intellectual property (IP), trademarks, equipment, and other assorted assets.

  • PAOG Expects To Add CBD Nutraceuticals Revenue This Year
    PR Newswire

    PAOG Expects To Add CBD Nutraceuticals Revenue This Year

    PAO Group, Inc. (USOTC: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the company's CBD nutraceutical development expansion plans. The presentation includes details on PAOG's strategic engagements with Puration, Inc. (USOTC: PURA), North American Cannabis Holdings, Inc. (USOTC: USMJ) and Alkme Holdings, Inc. (USOTC: ALKM).

  • PAOG Expects To Realize Revenue This Year From New CBD Nutraceuticals
    Newsfile

    PAOG Expects To Realize Revenue This Year From New CBD Nutraceuticals

    Sandusky, Ohio--(Newsfile Corp. - February 18, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the company's CBD nutraceutical development expansion plans. The presentation includes details on PAOG's strategic engagements with Puration, Inc. (OTC Pink: PURA), North American Cannabis Holdings, Inc. (OTC Pink: USMJ) and Alkmae Holdings, Inc. ...